Xolair Genentech, Inc. - Treatment for AsthmaXolair is a recombinant DNA-derived humanized IgG1 monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair is used to treat moderate to severe persistent asthma.
Posted: June 2003
- FDA Approves Genentech’s Xolair (omalizumab) for Allergic Asthma in Children - July 7, 2016
- FDA Approves Xolair (omalizumab) for Chronic Idiopathic Urticaria - March 21, 2014